Bethesda Memorial Hospital Testing Bat-Based Stroke Drug
Posted on: Tuesday, 5 July 2005, 12:01 CDT
Jul. 4--Vampire bats might soon become a stroke patient's best friend.
A new clot-busting drug for strokes being tested at Bethesda Memorial Hospital in Boynton Beach is a genetically engineered version of an ingredient found in vampire bat saliva.
Called desmoteplase, the drug dissolves blood clots in the brain and can be used within nine hours of a stroke. TPA, the clot-busting drug now used by most doctors for stroke patients, can only be used within three hours of the stroke and can cause excessive bleeding.
"Its effect is multiplied and more intense than TPA. It has less in the way of bleeding side effects," said Dr. Mark Brody, the neurologist leading the trial at Bethesda.
The drug is in the last phase of its clinical trial and could go before the Food and Drug Administration for approval by 2007.
Brody said the trial, which started Friday, will last about a year and a half and use the drug on about 300 people who come to Bethesda's emergency room with a stroke. The drug is made by Forest Laboratories.
"If it's successful, it would expand the number of people who could be treated because the window is so much longer," Brody said.
-----
To see more of The Palm Beach Post -- including its homes, jobs, cars and other classified listings -- or to subscribe to the newspaper, go to http://www.palmbeachpost.com.
Copyright (c) 2005, The Palm Beach Post, Fla.
Distributed by Knight Ridder/Tribune Business News.
For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-6515, or e-mail reprints@krtinfo.com.
FRX,
Source: The Palm Beach Post
Related Articles
- Pharmarama to Offer Comparator Drug Sourcing Services for Clinical Trials in China
- Avicena Signs Agreement With the National Institute of Neurological Disorders and Stroke for Phase III Trial for Novel Parkinson's Disease Candidate
- Metabolic's Neuropathic Pain Drug, ACV1, Enters Phase 2 Clinical Trials
- Lilly Drug to Undergo Alzheimer's Clinical Trial
- Drug Firms Fear Backlash After Trials Catastrophe
- Cook Launches Web Site for Patients Seeking Information About Peripheral Arterial Disease; Site Provides Information About Drug-Coated Stent in Clinical Trials
- OSI Diabetes Drug Moves to Phase I Clinical Trial
- Cancer Drug Being Tested in New Trial
- Drug Concerns Halt Major Alzheimer's Trial
- Obesity Drug Does Well in Human Trials
User Comments (0)

RSS Feeds